Potentiation of the L-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors.
D000328:Adult; D001921:Brain / Q000378:metabolism; D002396:Catechols; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*
D002396:Catechols; D004295:Dihydroxyphenylalanine; D008780:Methyltransferases